Ferroptosis:A therapeutic opportunity of inflammatory bowel disease  

作　　者：Yulin Ye Limin Liu Yang Jing Shuangzhe Yao Mo Yang Xin Dai Meiyu Piao Xin Xu Zelin Feng Xiaoli Wang Yifei Liu Junming Miao Xingjie Gao Qingxiang Yu Xiaocang Cao 

机构地区：[1]Department of Gastroenterology and Hepatology,Tianjin Medical University General Hospital,Tianjin Medical University,Tianjin 300070,China [2]Department of Biochemistry and Molecular Biology,School of Basic Medical Science,Tianjin Medical University,Tianjin 300070,China

出　　处：《Chinese Medical Journal》2024年第7期874-876,共3页中华医学杂志（英文版）

基　　金：National Natural Science Foundation of China(Nos.82270565 and 82100565);Scientific research project of Tianjin Municipal Commission of Education(No.2022KJ243)

摘　　要：To the Editor:Even to this day,the etiology and pathogenesis of inammatory bowel disease(IBD)are still unelucidated.Despite signicant progress in IBD treatment in recent years,some patients remain insensitive or non-responsive towards existing treatments.Therefore,further exploring IBD pathogenesis to develop novel therapeutic drugs or drug combinations is quite necessary.Recent studies have demonstrated the therapeutic potential of regulating cell death in IBD.The ferroptosis,a novel form of cell death,is also involved in the pathological process of IBD.

关 键 词：DRUGS DEATH TREATMENT 

分 类 号：R574[医药卫生—消化系统]